Pleasanton, Calif.—Apton Biosystems, Inc., a developer of Super-Res sequencing and single-molecule detection systems for large-scale clinical applications, such as early cancer detection and population sequencing, today announced the close of a $24 million Series-A financing. The financing was led by Kern Capital with participation by new and existing investors including Casdin Capital and Khosla Ventures. […]
Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the close of a $276 million Series C financing. New investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (Morgan Stanley), and T. Rowe Price joined existing investors Fidelity Management & Research Company, Foresite Capital, JS Capital Management LLC, RA Capital Advisors, and Venrock. With this latest investment, Element Biosciences […]
Wellington, New Zealand – Wellington-based deep tech startup Marama Labs has secured $1.25m in new funding in a round co-led by US-based venture capital firm Quidnet Ventures and New Zealand Growth Capital Partners (NZGCP), with support from several New Zealand investors. Marama Labs’ chemical analysis tools give industrial customers, such as wineries, unique chemical insights […]
We are delighted to have been awarded a grant of up to £320,000 from Innovate UK, the UK’s innovation agency, for the research and development of a 100L bioreactor for stem cell applications. Our existing range Our existing range of patented airlift, single-use bioreactors includes the CellMaker Systems: Regular, Low Flow and Plus – created […]
Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. The funded project aims to make further improvements on HiDef-B8, the company’s flagship product and fully defined medium supplement for human induced pluripotent stem (iPS) cells. First published by the […]
Highlights Trajan Group Holdings Limited raises $90 million in an Initial Public Offering (IPO) Strong investor demand attracting top tier Australian, Asian, UK and NZ institutions 300+ employees participate via employee gift and ESOP, reflecting Trajan’s ‘people first’ culture Listing confirmed for 7th June 2021, 10.30am Melbourne, Australia – Global analytical science and device company […]
LA JOLLA, Calif. — Singular Genomics Systems, Inc. (“Singular Genomics”), a company focused on delivering genomic technologies for the advancement of science and medicine, today announced the closing of its initial public offering of 11,730,000 shares of its common stock, which includes the full exercise of the underwriters’ option to purchase 1,530,000 additional shares of […]
Capital will enable continued advancement of GenapSys’ electronic-based, next-generation sequencing platform REDWOOD CITY, Calif. — GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced it has raised $70 million in a Series D equity financing. Investors in the round included Farallon Capital Management, L.L.C., Soleus Capital, an affiliate of PBM […]
Largest private financing round by an Asia-based life sciences tools company Important milestone in the development of Novo Holdings’ ambitions in Asia As a result of the financing, Amit Kakar, Senior Partner, Head of Novo Holdings Asia will join the company’s Board of Directors Singapore & Copenhagen, Denmark – Novo Holdings today announced that it […]
Largest private fundraising round by an Asia-based life sciences tools company SINGAPORE — Esco Lifesciences (“Esco”, the “Company”) announced today the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Novo Holdings A/S, with participation from new investors including China Investment Corporation, Singapore-based global investor EDBI, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
